Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule
SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the months of May and June.
On May 25th, 2022, at 7:45 a.m. PT, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the UBS Global Healthcare Conference being held in New York City, New York.
On June 8th, 2022, at 8:40 a.m. PT, Mr. Herde will present at the William Blair Growth Conference being held in Chicago, Illinois.
On June 14th, 2022, at 2:40 p.m. PT, Mr. Herde will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference being held in Rancho Palos Verdes, California.
A live webcast of the presentations will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under Events and Presentations. An archived version of the webcasts will also be available on the Maravai website following the completion of each event.
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologic safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. For more information about Maravai LifeSciences, visit www.maravai.com.
Contact Information: Media Contact: Sara Michelmore MacDougall Advisors +1 781-235-3060 email@example.com Investor Contact: Deb Hart Maravai LifeSciences + 1 858-988-5917 firstname.lastname@example.org
Released May 11, 2022